Annex

United Kingdom

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘tulathromycin’ is replaced by the following:

Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic classification
‘Tulathromycin (2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2-ethyl-3,4,10,13-tetra-hydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethy-lamino)-ß-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopent-decan-15-one expressed as tulathromycin equivalents Ovine, caprine 450 μg/kg Muscle Not for use in animals from which milk is produced for human consumption Anti-infectious agents/Antibiotics’
250 μg/kg Fat
5 400 μg/kg Liver
1 800 μg/kg Kidney
Bovine 300 μg/kg Muscle
200 μg/kg Fat
4 500 μg/kg Liver
3 000 μg/kg Kidney
Porcine 800 μg/kg Muscle
300 μg/kg Skin and fat in natural proportions
4 000 μg/kg Liver
8 000 μg/kg Kidney

Pharmacologically active Substance	Marker residue	Animal Species	MRL	Target Tissues	Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic classification
‘Tulathromycin	(2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2-ethyl-3,4,10,13-tetra-hydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethy-lamino)-ß-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopent-decan-15-one expressed as tulathromycin equivalents	Ovine, caprine	450 μg/kg	Muscle	Not for use in animals from which milk is produced for human consumption	Anti-infectious agents/Antibiotics’
			250 μg/kg	Fat
			5 400 μg/kg	Liver
			1 800 μg/kg	Kidney
		Bovine	300 μg/kg	Muscle
			200 μg/kg	Fat
			4 500 μg/kg	Liver
			3 000 μg/kg	Kidney
		Porcine	800 μg/kg	Muscle
			300 μg/kg	Skin and fat in natural proportions
			4 000 μg/kg	Liver
			8 000 μg/kg	Kidney